International Journal of Hematology and Oncology 2025 , Vol 35 , Num 2
Fatih YAY, Fatih KUS, Gokhan SAHIN, Hasan Cagri YILDIRIM, Suayib YALCIN Bioinformatics Analysis of IGSF9B Gene in Patients Diagnosed with Colorectal Carcinoma. UHOD , 2025 , 35 , 075-085



Oktay BOZKURT, Ugur TURKMEN, Kemal DENIZ, Sedat Tarik FIRAT, Ramazan COSAR, Ender DOGAN, Mevlude INANC, Metin OZKAN Prognostic Significance of Glyoxalase-1 Enzyme Activity in Metastatic Pancreatic Cancer Patients. UHOD , 2025 , 35 , 086-094



Najwa DABOUL, Serife Efsun ANTMEN, Cem YALAZA, Ferah TUNCEL, Hakan AYTAN, Sema Erden ERTURK Reconfiguration of Lipid Metabolism and SCAP-SREBP Pathway in Endometrial Carcinoma. UHOD , 2025 , 35 , 096-103



Ali Kaan GUREN, Nazim Can DEMIRCAN1 DEMIRCAN, Sedef Seyma OZGUR, Tugce BULUN AKYOL, Nargiz MAJIDOVA, Erkam KOCAASLAN, Yesim AGYOL, Pinar EREL, Burak PACACI, Mustafa Alperen TUNC, Nadiye SEVER, Abdussamet CELEBI, Rukiye ARIKAN, Selver ISIK, Murat SARI, Osman KOSTEK, Ibrahim Vedat BAYOGLU Clinicopathological Features and Survival Outcomes of Colorectal Cancer Patients Under 40 Years: A 20-Years Single-Center Experience. UHOD , 2025 , 35 , 104-111



Oguzcan OZKAN, Asli GECGEL, Pinar PEKER, Gurdeniz SERIN, Osman ZEKIOGLU, Erhan GOKMEN How Does Ki-67 Expression Vary Between Core Needle Biopsy and Surgical Specimens in Untreated Early-Stage Breast Cancer?. UHOD , 2025 , 35 , 112-120



Unal ATAS, Ayse KARADURU, Sait Emir SAHIN, Erdal KURTOGLU, Volkan KARAKUS Infection Burden and Survival Outcomes in Multiple Myeloma Patients with Acquired Hypogammaglobulinemia Receiving Antibiotic Prophylaxis without IVIG: A Single-Center Real-World Study. UHOD , 2025 , 35 , 121-130



Arif Hakan ONDER, Kubra Demir ONDER, Yesim CEKIN, Banu OZTURK, Erdal KURTOGLU Evaluating the Reciprocal Effects of COVID-19 Vaccines and Immunotherapy on Oncology Patients Receiving Immunotherapy. UHOD , 2025 , 35 , 131-149



Handan UZUNCAKMAK-UYANIK, Cagri Mesut TEMUCIN, Zafer ARIK, Elifcan ALADAG, Fatma Gokcem YILDIZ Glimpse into Routine EMG Findings of Patients with Malign Neoplasms. UHOD , 2025 , 35 , 150-157